Aclaris Therap
ACRS----
Aclaris Therap (ACRS)
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-i...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Aclaris Therap Analyst Rating
View MoreForecast & Rating
Jul 16, 2026Price forecast
$10.0084.50%
Forecast & RatingStrong buy
11analysts
- Strong buy81.82%
- Buy9.09%
- Hold9.09%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 2 days ago, 02:45 AM
Biotech Stocks At 52-Week Highs - XNCR, COAG, MNPR, SOPH, ACRS
- PUBT · Jul 15 at 12:38 PM
Aclaris publishes corporate presentation outlining inflammatory and immunology pipeline, 2026 clinical catalysts
- MSN · Jul 3 at 07:21 AM
These low-priced stocks are flashing overbought signals
- benzinga_article · Jun 22 at 07:02 AM
SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Market Beat · Jun 20 at 08:20 AM
3 Penny Stocks Under $5 Backed by Real Revenue Growth
- Market Beat · Jun 4 at 02:02 PM
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
